Literature DB >> 1518296

Late relapse and mortality in stage I large bowel cancer.

G J Hill1, B C Ghosh.   

Abstract

The outcome was determined for patients with Stage I cancers of the large bowel (colon, rectum, and anus) who were treated from 1982-1989. In 119 consecutive patients, the 5-year survival was approximately 70% (72% by the absolute direct method; 67% by the actuarial life table method). Although the overall 5-year survival was similar to numerous other published reports, it was disturbing to observe that 41% of the living patients had relapsed. Furthermore, although 88/119 (67%) were alive at last report, 2-7 years after treatment, only 23 (19%) were believed to be free of cancer. We conclude that follow-up for more than 5 years and the assessment of disease-free survival are required to evaluate the outcome from Stage I large bowel cancer.

Entities:  

Mesh:

Year:  1992        PMID: 1518296     DOI: 10.1002/jso.2930510114

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study.

Authors:  Carmela Di Gregorio; Piero Benatti; Lorena Losi; Luca Roncucci; Giuseppina Rossi; Giovanni Ponti; Massimiliano Marino; Monica Pedroni; Alessandra Scarselli; Barbara Roncari; Maurizio Ponz de Leon
Journal:  Int J Colorectal Dis       Date:  2004-12-09       Impact factor: 2.571

2.  Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy.

Authors:  Marco Tampellini; Maria Pia Brizzi; Raffaella Bitossi; Irene Alabiso; Carla Maria Sculli; Luigi Chiusa; Mauro Papotti; Luigi Dogliotti
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-06       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.